Lanadelumab Injection - Shire
A Contract Award Notice
by BELFAST HEALTH AND SOCIAL CARE TRUST
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £300K
- Sector
- HEALTH
- Published
- 12 Feb 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
BELFAST
Geochart for 2 buyers and 1 suppliers
2 buyers
1 supplier
Description
Lanadelumab Injection - Shire
Award Detail
| 1 | Shire Pharmaceuticals Part of Takeda Pharmaceutical (London)
|
Award Criteria
| PRICE | _ |
CPV Codes
- 33000000 - Medical equipments, pharmaceuticals and personal care products
Indicators
- Award on basis of price.
Legal Justification
This is a branded patent protected medicine for the treatment of hereditary angioedema which is only available from Shire Pharmaceuticals
Reference
- FTS 002925-2021